ArticleCancers2022

ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors.

David Pladevall-Morera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.